enGene Therapeutics Inc (NAS:ENGN)
$ 1.71 +0.030 (+1.78%) Market Cap: 115.22 Mil Enterprise Value: -109.89 Mil PE Ratio: 0 PB Ratio: 0.45 GF Score: 12/100

enGene Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 09, 2026 / 12:30PM GMT
Release Date Price: $1.67 (+1.21%)
Ron Cooper
enGene Therapeutics Inc - Chief Executive Officer

Good morning and welcome to the Annual Meeting of Shareholders of enGene Therapeutics Inc. My name is Ronald Cooper, and I'm the Chief Executive Officer, President and the Director of the company.

As this meeting is being held virtually via webcast, we would like to set a few operational rules for the orderly conduct of the meeting. One, for the purposes of the meeting voting on all matters will be conducted by electronic ballot through the Broadridge virtual meeting platform. Only registered shareholders and duly appointed proxy holders who have properly logged in with their control number will be able to vote on each business item. Beneficial shareholders would have needed to register in advance to receive a control number. Once the voting is confirmed, click the Vote Here button on the right-hand side. To vote, simply select your voting direction from the option shown on the screen and click Submit.

A confirmation message will appear to show your vote has been received. If you have additional control numbers to vote, you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot